Rosen, MD, and Julie Ingelfinger, MD, from Tufts University School of Medicine and the Maine Medical Center Institute for Research (MaineHealth): #Endocrinology To view or add a comment, sign in Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure
Persistent stomach pain, which may or may not feel severe Pain that radiates from the abdomen to the back, with or without vomiting Fever Jaundice (yellowing skin or eyes) Clay-colored stool Swelling of your face, lips, tongue, or throat Feeling faint or dizzy Difficulty breathing or swallowing Rapid heartbeat Severe rash or itching Sweating Confusion Blurred vision Slurred speech Shakiness Feeling jittery Weakness Mood changes Vision changes Suicidal thoughts How long does it take for Zepbound to start working
Directions for Use: Semaglutide or Tirzepatide In evaluating the appropriate therapy, as a pharmacist I recommend considering several factors: Blood Glucose Targets: For those needing substantial HbA1c reduction, tirzepatide might be preferred due to its higher efficacy at maximum doses
FDA warnings about semaglutide dosing errors This is not theoretical